LNK-01004

N/A

Report date: 2026/05/26 14:54:58
NME

Base Information

Drug NameLNK-01004
Drug Alias NameLNK-01004
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionJanus kinase inhibitors
TargetsJanus kinase
Therapy Area/IndicationsPsoriasisVitiligoEczema +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesLynk Pharmaceutical (Hangzhou) Co Ltd
Inactive CompaniesN/A
Active IndicationsPsoriasisVitiligoEczema +[6] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A